Improving the cultivation of large bioprinted tissues could help make laboratory-grown tissue models more reliable for drug development and regenerative…
Downstream processing is becoming a bottleneck as biopharmaceutical manufacturing shifts to more complex bispecific antibodies, FC-fusion proteins, and adeno-associated viral…
Credit: Westend61/Getty Images Nova Biomedical acquired certain assets of NanoCellect, which develops microfluidic cell sorting technology, to expand its capabilities…